Stelara 45 MG/0.5 ML syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FEDWL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,317
Award facts
- Contract value 100% obligated
- $24,317.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,317.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of STELARA 45 mg/0.5 ml syringes on June 18, 2025, with an ultimate completion date of June 20, 2025. This non-set-aside contract was awarded competitively and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. STELARA (ustekinumab) is a biologic immunosuppressant medication commonly used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and inflammatory bowel disease, making this a critical pharmaceutical procurement for military healthcare operations.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As one of the largest pharmaceutical distributors supporting federal medical procurement, AmerisourceBergen Drug Corp fulfills a critical role in supplying brand-name and generic medications, vaccines, and medical devices to the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The company's extensive contract portfolio demonstrates its capability to meet federal pharmaceutical requirements across multiple therapeutic domains through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB25FEDWL?
SPE2DB25FEDWL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 18, 2025.
How much is contract SPE2DB25FEDWL worth?
The government has obligated $24,317 on SPE2DB25FEDWL.
Is contract SPE2DB25FEDWL an order under another contract?
Yes. SPE2DB25FEDWL is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEDWL competed?
The extent of competition for SPE2DB25FEDWL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award